Cargando…

Aberrant cell signalling in PBMCs upon IFN‐α stimulation in primary Sjögren's syndrome patients associates with type I interferon signature

Primary Sjögren's syndrome (pSS) is a complex systemic autoimmune disease with heterogeneous disease manifestations. Genetic predisposition, hormonal and environmental factors are all thought to contribute to disease etiology and pathogenesis. A better understanding of the disease pathogenesis...

Descripción completa

Detalles Bibliográficos
Autores principales:	Davies, Richard, Hammenfors, Daniel, Bergum, Brith, Vogelsang, Petra, Gavasso, Sonia, Brun, Johan G., Jonsson, Roland, Appel, Silke
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2018
Materias:	Immunodeficiencies and autoimmunity
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6585835/ https://www.ncbi.nlm.nih.gov/pubmed/29604049 http://dx.doi.org/10.1002/eji.201747213

Ejemplares similares

Aberrant signaling of immune cells in Sjögren’s syndrome patient subgroups upon interferon stimulation
por: Sarkar, Irene, et al.
Publicado: (2022)

Single Cell Based Phosphorylation Profiling Identifies Alterations in Toll-Like Receptor 7 and 9 Signaling in Patients With Primary Sjögren's Syndrome
por: Davies, Richard, et al.
Publicado: (2019)

Impaired activation of STAT5 upon IL-2 stimulation in Tregs and elevated sIL-2R in Sjögren’s syndrome
por: Keindl, Magdalena, et al.
Publicado: (2022)

Lymph node biopsy analysis reveals an altered immunoregulatory balance already during the at‐risk phase of autoantibody positive rheumatoid arthritis
por: Ramwadhdoebe, Tamara H., et al.
Publicado: (2016)

Granulocyte‐augmented chemokine production induced by type II collagen containing immune complexes is mediated via TLR4 in rheumatoid arthritis patients
por: Manivel, Vivek Anand, et al.
Publicado: (2016)

CXCL4 is a novel inducer of human Th17 cells and correlates with IL‐17 and IL‐22 in psoriatic arthritis
por: Affandi, Alsya J., et al.
Publicado: (2018)

Protein tyrosine phosphatase PTPN22 regulates IL‐1β dependent Th17 responses by modulating dectin‐1 signaling in mice
por: Purvis, Harriet A, et al.
Publicado: (2017)

Induced CNS expression of CXCL1 augments neurologic disease in a murine model of multiple sclerosis via enhanced neutrophil recruitment
por: Grist, Jonathan J., et al.
Publicado: (2018)

Human neonatal thymectomy induces altered B‐cell responses and autoreactivity
por: van den Broek, Theo, et al.
Publicado: (2017)

The macrophage migration inhibitory factor pathway in human B cells is tightly controlled and dysregulated in multiple sclerosis
por: Rijvers, Liza, et al.
Publicado: (2018)

Enhancing immunity prevents virus‐induced T‐cell‐mediated immunopathology in B cell‐deficient mice
por: Straub, Tobias, et al.
Publicado: (2019)

Dysregulated CD46 shedding interferes with Th1‐contraction in systemic lupus erythematosus
por: Ellinghaus, Ursula, et al.
Publicado: (2017)

A mouse model of systemic lupus erythematosus responds better to soluble TACI than to soluble BAFFR, correlating with depletion of plasma cells
por: Haselmayer, Philipp, et al.
Publicado: (2017)

Impaired proteolysis by SPPL2a causes CD74 fragment accumulation that can be recognized by anti‐CD74 autoantibodies in human ankylosing spondylitis
por: van Kempen, Tessa S., et al.
Publicado: (2020)

Presence, function, and regulation of IL‐17F‐expressing human CD4(+) T cells
por: Burns, Lachrissa A., et al.
Publicado: (2020)

CD4(+)CCR6(+) T cells, but not γδ T cells, are important for the IL‐23R‐dependent progression of antigen‐induced inflammatory arthritis in mice
por: Razawy, Wida, et al.
Publicado: (2019)

Dysregulated RASGRP1 expression through RUNX1 mediated transcription promotes autoimmunity
por: Baars, Matthijs J.D., et al.
Publicado: (2020)

Genetic dissection of a major haplotype associated with arthritis reveal FcγR2b and FcγR3 to act additively
por: Vaartjes, Daniëlle, et al.
Publicado: (2020)

Circulating ILC precursors expressing CD62L exhibit a type 2 signature distinctly decreased in psoriatic patients
por: Campana, Stefania, et al.
Publicado: (2021)

Targeting Bcl6 in the TREX1 D18N murine model ameliorates autoimmunity by modulating T‐follicular helper cells and germinal center B cells
por: Venkatadri, Rajkumar, et al.
Publicado: (2022)

Follicular helper T cell signature of replicative exhaustion, apoptosis, and senescence in common variable immunodeficiency
por: Milardi, Giulia, et al.
Publicado: (2022)

Antigen receptor‐engineered Tregs inhibit CNS autoimmunity in cell therapy using nonredundant immune mechanisms in mice
por: Pohar, Jelka, et al.
Publicado: (2022)

Phospholipase activity of acyloxyacyl hydrolase induces IL‐22‐producing CD1a‐autoreactive T cells in individuals with psoriasis
por: Singh, Randeep, et al.
Publicado: (2022)

ACKR1 favors transcellular over paracellular T‐cell diapedesis across the blood‐brain barrier in neuroinflammation in vitro
por: Marchetti, Luca, et al.
Publicado: (2021)

Novel homozygous CD46 variant with C‐isoform expression affects C3b inactivation in atypical hemolytic uremic syndrome
por: Schack, Vivien R., et al.
Publicado: (2022)

Toll‐like receptors control the accumulation of neutrophils in lymph nodes that expand CD4(+) T cells during experimental autoimmune encephalomyelitis
por: Shen, Ping, et al.
Publicado: (2022)

Rheumatoid arthritis, systemic lupus erythematosus and primary Sjögren’s syndrome shared megakaryocyte expansion in peripheral blood
por: Wang, Yukai, et al.
Publicado: (2022)

Practical challenges for functional validation of STAT1 gain of function genetic variants
por: Albuquerque, Adriana S, et al.
Publicado: (2023)

Association between T follicular helper cells and T peripheral helper cells with B-cell biomarkers and disease activity in primary Sjögren syndrome
por: Dupré, Anastasia, et al.
Publicado: (2021)

Associations between nailfold capillary aberrations and autoantibodies in children and adults with Raynaud’s phenomenon
por: Mueller, Markus, et al.
Publicado: (2023)

Interferon signature in systemic autoimmune diseases: what does it mean?
por: Nocturne, Gaetane, et al.
Publicado: (2022)

Diagnostic markers and potential therapeutic agents for Sjögren’s syndrome screened through multiple machine learning and molecular docking
por: Zhou, Liqing, et al.
Publicado: (2023)

Suppression of IRAK1 or IRAK4 Catalytic Activity, but Not Type 1 IFN Signaling, Prevents Lupus Nephritis in Mice Expressing a Ubiquitin Binding–Defective Mutant of ABIN1
por: Nanda, Sambit K., et al.
Publicado: (2016)

Type I interferon pathway assays in studies of rheumatic and musculoskeletal diseases: a systematic literature review informing EULAR points to consider
por: Burska, Agata, et al.
Publicado: (2023)

Antibodies against carbamylated proteins are present in primary Sjögren's syndrome and are associated with disease severity
por: Bergum, Brith, et al.
Publicado: (2016)

Association between type I interferon pathway activation and clinical outcomes in rheumatic and musculoskeletal diseases: a systematic literature review informing EULAR points to consider
por: Rodríguez-Carrio, Javier, et al.
Publicado: (2023)

Altered phenotype and Stat1 expression in Toll-like receptor 7/8 stimulated monocyte-derived dendritic cells from patients with primary Sjögren’s syndrome
por: Vogelsang, Petra, et al.
Publicado: (2014)

Clinical and Cost Burden of Primary Sjögren’s Syndrome: Descriptive Analysis Using a US Administrative Claims Database
por: Perera, Sue, et al.
Publicado: (2018)

Functional Analysis of a Complement Polymorphism (rs17611) Associated with Rheumatoid Arthritis
por: Giles, Joanna L., et al.
Publicado: (2015)

Cancer immunotherapy-induced rheumatic diseases emerge as new clinical entities
por: Cappelli, Laura C, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_3dpruhbo29vm4se35kke2tn9f6